ClinicalTrials.govpublic full text
T Cells Expressing Fully-human Anti-CD19 and Anti-CD20 Chimeric Antigen Receptors for Treating B-cell Malignancies and Hodgkin Lymphoma
lymphoma, b-cell, lymphoma, non-hodgkins, chronic lymphocytic leukemia, b-cell chronic lymphocytic leukemia, autologous t cells infusion, hu1928-hu20bb, hodgkin reed-sternberg cells, adoptive t cell therapy, gene therapy, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 875562
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.